Showing results (61-70 of 270) with videos related to
Sort By:
Pageof 27
Lancet (London, England)|November 6, 1982
Bone-marrow transplantation for acute leukaemia in first remissionR P Gale, H E Kay, A A Rimm, et al.JAMA|March 4, 1983
Bone marrow transplantation for acute myelogenous leukemia. Factors associated with early mortalityM M Bortin, R P Gale, H E Kay, et al.Lancet (London, England)|February 20, 1982
Factors associated with interstitial pneumonitis after bone-marrow transplantation for acute leukaemiaM M Bortin, H E Kay, R P Gale, et al.Lancet (London, England)|March 19, 1983
Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemiaR L Powles, G R Morgenstern, H E Kay, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|January 1, 1997
Metastatic breast cancer 42 years after bilateral subcutaneous mastectomiesM B Jameson, E Roberts, J Nixon, et al.ANZ Journal of Surgery|November 1, 2013
Prognostic molecular markers in head and neck squamous cell carcinoma in a New Zealand population: matrix metalloproteinase-2 and sialyl Lewis x antigenIndunil Gunawardena, Michael Arendse, Michael B Jameson, et al.Journal of Clinical Pharmacy and Therapeutics|September 21, 2019
Doxorubicin and cyclophosphamide-induced parotitis: A case reportAndrew Fox-Lewis, Mohammed Tairab, Graham Fulton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2008
Population pharmacokinetic-pharmacodynamic model of the vascular-disrupting agent 5,6-dimethylxanthenone-4-acetic acid in cancer patientsJing Li, Michael B Jameson, Bruce C Baguley, et al.Nature Chemistry|August 3, 2023
Hetero-interpenetrated metal-organic frameworksDavid Perl, Seok J Lee, Alan Ferguson, et al.Chemical Communications (Cambridge, England)|July 23, 2011
Photolabile protecting groups in metal-organic frameworks: preventing interpenetration and masking functional groupsRajesh K Deshpande, Geoffrey I N Waterhouse, Geoffrey B Jameson, et al.Pageof 27